Загрузка...
Patient-reported outcomes in a trial of exenatide and insulin glargine for the treatment of type 2 diabetes
BACKGROUND: Patient-reported measures can be used to examine whether drug differences other than clinical efficacy have an impact on outcomes that may be important to patients. Although exenatide and insulin glargine appear to have similar efficacy for treatment of type 2 diabetes, there are several...
Сохранить в:
Главные авторы: | , , , , , , |
---|---|
Формат: | Artigo |
Язык: | Inglês |
Опубликовано: |
BioMed Central
2006
|
Предметы: | |
Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1634743/ https://ncbi.nlm.nih.gov/pubmed/17034640 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-7525-4-80 |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|